BRS4(FM3) - Substrate Utilisation Flexibility
(Switching Fuels for Steady Energy)
1. Definition
A functional control point governing mitochondrial capacity to transition between glucose, fatty acids, ketones, and mixed substrates efficiently under changing metabolic demand (metabolic fuel flexibility).
- Transports long-chain fatty acids into mitochondria for β-oxidation.
- Utilises ketone bodies as alternative energy substrates when glucose availability shifts.
- Switches between glucose-derived, fatty-acid-derived, and ketone-derived ATP production.
2. Primary Biological Effects
↑ fatty-acid oxidation flexibility; ↑ ketone utilisation capacity; ↑ metabolic fuel switching; ↑ metabolic adaptability
3. Phenome Connections
These outcomes describe translational contexts for the FM as an integrated biological capacity. They are not single-mechanism treatment claims. Biology → Phenome Confidence reflects biological relevance to each outcome — not proof that diet or lifestyle alone will improve it. Evidence Confidence (below Key References) reflects how convincing the attached evidence is for the Biology → Phenome relationship on that row. FM confidence uplift: FM confidence may exceed that of any individual child PM only where multiple PMs converge on the same phenome and the integrated FM biology provides additional biological rationale (biological uplift) beyond the individual mechanisms.
These are three independent scores. They are not combined or averaged. A phenome can have Medium registry evidence while individual mechanism rows show different Biology → Phenome and Evidence scores.
1. Phenome Evidence Confidence (Phenome Registry only)
Question: How convincing is the foundational evidence that this phenome is a valid, well-defined functional construct — and that diet-relevant biology can plausibly connect to it?
Not a roll-up of Biology → Phenome Confidence or Evidence Confidence from Primary Mechanism page rows. Those are scored per mechanism; this score is assigned once per phenome at registry level.
Derived from foundational landmark evidence organised in up to three layers: construct validation, biology→phenome linkage, and nutrition→biology modulation. Each layer may include one or many landmark papers depending on registry review.
2. Biology → Phenome Confidence (Primary Mechanism page §3 rows)
Question: If this PM/FM biology were substantially impaired in isolation, how directly would that phenome be expected to suffer — within BRAIN architecture?
How it is derived: Reviewers read the PM/FM definition and biological function first — initially ignoring attached references and whether dietary intervention studies exist. References are reviewed only when scoring Evidence Confidence (below).
Score levels (the value shown on each row as Biology → Phenome Confidence):
- High — primary biological determinant (e.g. noradrenergic signalling → attention; GABA synthesis → calming tone)
- Medium — major contributory determinant, not the sole driver
- Low–Medium — established but indirect, modulatory, or one integrative step removed
- Low — distal, conditional, or weak biological coupling
“Not dietary treatment efficacy” means this score does not ask whether a diet or supplement treats the phenome. It asks whether the biology itself is architecturally relevant. Limited dietary RCT evidence belongs in Evidence Confidence, not here.
3. Evidence Confidence (Primary Mechanism page §3 rows)
Question: How convincing are the attached Key References on that specific row that this biology actually relates to this phenome?
How it is derived: Assigned after Biology → Phenome Confidence, by reviewing only the references on that PM/FM row. Judges whether refs support the relationship — not just mechanism or phenome in isolation.
- High — strong convergent human evidence directly linking mechanism biology to phenome variation
- Medium — multiple human lines supporting the relationship; may include one bridge study with an inferential step
- Low–Medium — convergent translational stack without direct mechanism↔phenome measurement on the row
- Low — mechanistic or preclinical only; mechanism and phenome supported separately but not bridged
Often equal to or lower than Biology → Phenome Confidence. Can occasionally be higher when outcome evidence is stronger than the mechanism's contributory role.
- Biology → Phenome Confidence: Medium
- Synthesis: Integrated carnitine-mediated fat transport, ketone utilisation, and adaptive fuel switching may help stabilise mental energy when glucose availability or metabolic demand shifts, with converging support across all three child mechanisms, although direct ADHD-specific outcome evidence remains limited.
- Key References:
- van Oudheusden and Scholte (2002) — Human Outcome
- Goodpaster & Sparks (2017) — Mechanistic
- Ramezani et al. (2023) — Mechanistic
- Smith et al. (2018) — Mechanistic
- Evidence Confidence: Medium
- Biology → Phenome Confidence: Low–Medium
- Synthesis: Broader substrate flexibility — spanning fatty-acid transport, ketone metabolism, and pathway switching — may expand the conditions under which mitochondrial energy production can be sustained, with multiple child mechanisms converging on this outcome.
- Key References:
- Kyriazis et al. (2022) — Mechanistic
- López-Ojeda et al. (2023) — Mechanistic
- Smith et al. (2018) — Mechanistic
- Goodpaster & Sparks (2017) — Mechanistic
- Evidence Confidence: Low–Medium
- Biology → Phenome Confidence: Low
- Synthesis: Adaptive fuel selection and substrate flexibility may indirectly support recovery from periods of increased metabolic demand, although direct outcome evidence at the integrated FM level remains limited.
- Key References:
- Evidence Confidence: Low
4. Mechanistic Basis (Integrated FM Narrative)
Substrate utilisation flexibility emerges from the coordinated interaction of several primary mechanisms and supporting biological pools.
4.1 Core Primary Mechanisms
- BRS4-FM3-PM6 — Carnitine-Mediated Fat Transport Transport of long-chain fatty acids into mitochondria for β-oxidation.
- BRS4-FM3-PM7 — Ketone Utilisation Capacity Transport, metabolism, and utilisation of ketone bodies as alternative mitochondrial energy substrates.
- BRS4-FM3-PM8 — Metabolic Fuel Switching Adaptive transition between glucose, fatty-acid, and ketone energy pathways according to substrate availability and demand.
4.2 Integrated Functional Narrative
Together, this PM operationalises BRS4(FM3) as substrate utilisation flexibility.
At the integrated FM level, flexibility does not mean fixed reliance on one fuel. It means maintaining the capacity to process and transition between mixed substrates—including glucose, fatty acids, and ketone bodies—appropriately when demand and metabolic context shift [Kyriazis et al., 2022; van Oudheusden and Scholte, 2002].
4.3 Suboptimal Function & Its Effects
Substrate utilisation flexibility may weaken when macronutrient substrate availability, or mitochondrial cofactor sufficiency become inadequate, or when supporting biological pools are chronically strained.
Chronic energy deficit or under-fuelling may reduce BRS4(KC1) — Macronutrient Substrate Availability. Erratic meal patterns reducing substrate continuity may further strain pool availability, ultra-processed food patterns with poor fuel quality, low protein intake where amino-acid support is needed, while metabolic or inflammatory burden increasing energetic demand.
Low micronutrient density across the diet may reduce BRS4(KC2) — Mitochondrial Cofactor Sufficiency. Restrictive or low-variety dietary patterns may further strain pool availability, chronic oxidative or inflammatory burden increasing cofactor demand, impaired absorption or depletion states, while high energy intake with poor micronutrient quality.
These pressures may impair BRS4-FM3-PM6 — Carnitine-Mediated Fat Transport, BRS4-FM3-PM7 — Ketone Utilisation Capacity, and BRS4-FM3-PM8 — Metabolic Fuel Switching. At the FM level, this may shift BRS4(FM3) toward reduced substrate utilisation flexibility performance.
4.4 Evidence Highlights
Introduction/Summary
The studies below support substrate utilisation flexibility as an integrated FM state emerging from coordinated child PM biology — mechanism-qualifying findings that refine framework interpretation, not phenome/outcome science (which belongs in §3).
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Carnitine enables long-chain fatty-acid import for β-oxidation when glucose availability or metabolic demand shifts — enabling mitochondrial import of long-chain fatty acids for β-oxidation [Kyriazis et al., 2022].
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Ketone bodies can be transported to the brain and oxidised within mitochondria to support ATP production during reduced glucose availability [Ramezani et al., 2023; López-Ojeda et al., 2023]. This establishes ketone utilisation as a legitimate alternative fuel pathway within substrate flexibility — not a universal dietary prescription.
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Butyrate supports mitochondrial function and brain energy metabolism, while also contributing to lower neuroinflammatory load [Rose et al., 2018]. This links gut-derived SCFA biology to the integrated fuel-switching capacity represented by this PM — primarily via permissive metabolic context rather than direct PM intervention claims.
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Metabolic flexibility describes the capacity to transition between glucose, fatty acids, and ketones according to physiological demand [Goodpaster & Sparks, 2017; Smith et al., 2018]. Within BRS4(FM3), fuel switching sits above carnitine transport and ketone utilisation as the integrative adaptive capability.
- Key References:
5. Connected Mechanisms
- BRS4-FM1-PM1 - Electron Transport Chain Function — electron Transport Chain Function
- BRS4-FM1-PM2 - NAD⁺ Metabolism — nAD⁺ Metabolism
- BRS6-FM1-PM2 - Glycaemic Variability Regulation — biological connection relevant to this mechanism
6. References
- Kyriazis et al. (2022) — Impact of Diet Upon Mitochondrial Physiology (Review)
- van Oudheusden and Scholte (2002) — Efficacy of Carnitine in the Treatment of Children with Attention-deficit Hyperactivity Disorder
- Goodpaster & Sparks (2017) — Metabolic Flexibility in Health and Disease
- Ramezani et al. (2023) — Ketone Bodies Mediate Alterations in Brain Energy Metabolism and Biomarkers of Alzheimer's
- Smith et al. (2018) — Metabolic Flexibility As an Adaptation to Energy Resources and Requirements in Health
- López-Ojeda et al. (2023) — New Insights and Perspectives for Neurological Diseases
- Rose et al. (2018) — Butyrate and Brain Energy Metabolism